Xbrane Biopharma AB (XBRANE) — Strategic Asset Allocation Index
Xbrane Biopharma AB (XBRANE) has a Strategic Asset Allocation Index of 0.0% as of December 2025. Strategic assets (PP&E of Skr36.00K plus long-term investments of Skr-) total Skr36.00K, measured against net assets of Skr560.65 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Xbrane Biopharma AB Strategic Asset Allocation Index (2016–2025)
This chart shows how Xbrane Biopharma AB's Strategic Asset Allocation Index has evolved across 10 annual periods from 2016 to 2025. As of December 2025, the index stands at 0.0%, representing strategic assets of Skr36.00K against net assets of Skr560.65 Million SEK. Explore XBRANE operating cash flow to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Xbrane Biopharma AB (2016–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Xbrane Biopharma AB from 2016 to 2025, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see XBRANE market cap overview.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 0.0% | Skr36.00K | Skr36.00K | Skr- | Skr560.65 Million | ▼ -31.1 pp |
| 2024 | 31.1% | Skr64.90 Million | Skr64.90 Million | Skr- | Skr208.54 Million | ▼ -20.4 pp |
| 2023 | 51.5% | Skr88.20 Million | Skr88.20 Million | Skr- | Skr171.34 Million | ▲ +34.8 pp |
| 2022 | 16.7% | Skr71.05 Million | Skr71.05 Million | Skr- | Skr424.89 Million | ▼ -0.4 pp |
| 2021 | 17.1% | Skr73.80 Million | Skr73.80 Million | Skr- | Skr431.74 Million | ▲ +11.6 pp |
| 2020 | 5.5% | Skr14.13 Million | Skr14.13 Million | Skr- | Skr257.71 Million | ▼ -3.3 pp |
| 2019 | 8.8% | Skr16.21 Million | Skr16.21 Million | Skr- | Skr184.32 Million | ▼ -11.4 pp |
| 2018 | 20.2% | Skr16.74 Million | Skr16.74 Million | Skr- | Skr83.07 Million | ▼ -0.8 pp |
| 2017 | 21.0% | Skr18.57 Million | Skr18.57 Million | Skr- | Skr88.41 Million | ▲ +4.3 pp |
| 2016 | 16.7% | Skr17.88 Million | Skr17.88 Million | Skr- | Skr107.30 Million | — |